Stay updated on Pembrolizumab vs Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Atezolizumab Clinical Trial page.

Latest updates to the Pembrolizumab vs Atezolizumab Clinical Trial page
- Check3 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new service locations and the removal of outdated ones, as well as a service alert for planned maintenance starting July 25th.SummaryDifference5%
- Check11 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.5%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe webpage has been updated to reflect the latest results and details of a clinical trial for extensive-stage small cell lung cancer, including new dates for results posting and specific study parameters. Key changes include the addition of updated survival metrics and treatment protocols.SummaryDifference10%
- Check47 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
Stay in the know with updates to Pembrolizumab vs Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Atezolizumab Clinical Trial page.